Hopp til hovedinnhold

CIDP - kronisk inflammatorisk demyeliniserende polynevropati

Sist oppdatert: Sist revidert:
Sist revidert av:
  1. Bunschoten C, Jacobs BC, Van den Bergh PYK, Cornblath DR, van Doorn PA.. Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy.. Lancet Neurol. 2019; Aug;18(8):: 784-794. pmid:31076244 PubMed  
  2. Gwathmey K. Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Its Variants. Continuum (Minneap Minn). 2020 Oct;26(5):1205-1223. PMID: 33002999. PubMed  
  3. Uncini A, Mathis S, Vallat JM. New classification of autoimmune neuropathies based on target antigens and involved domains of myelinated fibres. J Neurol Neurosurg Psychiatry. 2022 Jan;93(1):57-67. PMID: 34373238. PubMed  
  4. Kieseier BC, Mathey EK, Sommer C, Hartung HP. Immune-mediated neuropathies. Nat Rev Dis Primers. 2018 Oct 11;4(1):31. doi: 10.1038/s41572-018-0027-2. PMID: 30310069. PubMed  
  5. Van den Bergh PYK, van Doorn PA, Hadden RDM, Avau B, Vankrunkelsven P, Allen JA, Attarian S, Blomkwist-Markens PH, Cornblath DR, Eftimov F, Goedee HS, Harbo T, Kuwabara S, Lewis RA, Lunn MP, Nobile-Orazio E, Querol L, Rajabally YA, Sommer C, Topaloglu HA. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision. J Peripher Nerv Syst. 2021 Jun 4. doi: 10.1111/jns.12455. Epub ahead of print. PMID: 34085743. PubMed  
  6. Mahdi-Rogers M, Hughes RA. Epidemiology of chronic inflammatory neuropathies in southeast England.. Eur J Neurol 2013. doi:10.1111/ene.12190 DOI  
  7. Beecher G, Shelly S, Dyck PJB, Mauermann ML, Martinez-Thompson JM, Berini SE, Naddaf E, Shouman K, Taylor BV, Dyck PJB, Engelstad J, Howe BM, Mills JR, Dubey D, Spinner RJ, Klein CJ. Pure Motor Onset and IgM-Gammopathy Occurrence in Multifocal Acquired Demyelinating Sensory and Motor Neuropathy. Neurology. 2021 Aug 10:10.1212/WNL.0000000000012618. doi: 10.1212/WNL.0000000000012618. Epub ahead of print. PMID: 34376509. PubMed  
  8. Fargeot G, Maisonobe T, Psimaras D, Debs R, Lenglet T, Adams D, Vandendries C, Labeyrie C, Viala K. Comparison of Lewis-Sumner syndrome with chronic inflammatory demyelinating polyradiculoneuropathy patients in a tertiary care centre. Eur J Neurol. 2020 Mar;27(3):522-528. PMID: 31574194. PubMed  
  9. Benoit C, Svahn J, Debs R, Vandendries C, Lenglet T, Zyss J, Maisonobe T, Viala K. Focal chronic inflammatory demyelinating polyradiculoneuropathy: Onset, course, and distinct features. J Peripher Nerv Syst. 2021 Mar 4. doi: 10.1111/jns.12438. Epub ahead of print. PMID: 33660880. PubMed  
  10. Khadilkar SV, Patel R, Shah N, Deshmukh ND, Patel BA, Mansukhani KA. Chronic immune polyradiculopathies: Three clinical variants of one disease? Muscle Nerve. 2020 Jul 25. PMID: 32710692. PubMed  
  11. Rajabally YA. The "chronic immune polyradiculopathies": Diverse but maybe just CIDP after all. Muscle Nerve. 2020 Sep 24. PMID: 32970333. PubMed  
  12. Ong S, Cassidy A. Chronic immune sensory polyradiculopathy (CISP). Pract Neurol. 2022 Feb;22(1):57-59. PMID: 34740963. PubMed  
  13. Ruiz M, Puthenparampil M, Campagnolo M, Castellani F, Salvalaggio A, Ruggero S, Toffanin E, Cacciavillani M, Gallo P, Franciotta D, Briani C. Oligoclonal IgG bands in chronic inflammatory polyradiculoneuropathies. J Neurol Neurosurg Psychiatry. 2021 Apr 13:jnnp-2020-325868. doi: 10.1136/jnnp-2020-325868. Epub ahead of print. PMID: 33850000. PubMed  
  14. Burnor E1, Yang L1, Zhou H1, Patterson KR1, Quinn C1, Reilly MM1, Rossor AM1, Scherer SS1, Lancaster E2.. Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies. Neurology. 2018. pmid: 29187518 PubMed  
  15. Pascual-Goñi E, Fehmi J, Lleixà C, Martín-Aguilar L, Devaux J, Höftberger R, Delmont E, Doppler K, Sommer C, Radunovic A, Carvajal A, Smyth S, Williams L, Mazanec R, Potočková V, Hinds N, Cassereau J, Viala K, Lefilliatre M, Nicolas G, Foley P, Leypoldt F, Keddie S, Lunn MP, Zimprich F, Nunkoo VS, Löscher WN, Martínez-Martínez L, Díaz-Manera J, Rojas-Garcia R, Illa I, Rinaldi S, Querol L. Antibodies to the Caspr1/contactin-1 complex in chronic inflammatory demyelinating polyradiculoneuropathy. Brain. 2021 May 7;144(4):1183-1196. doi: 10.1093/brain/awab014. PMID: 33880507. PubMed  
  16. Delmont E, Brodovitch A, Kouton L, Allou T, Beltran S, Brisset M, Camdessanché JP, Cauquil C, Cirion J, Dubard T, Echaniz-Laguna A, Grapperon AM, Jauffret J, Juntas-Morales R, Kremer LD, Kuntzer T, Labeyrie C, Lanfranco L, Maisonobe T, Mavroudakis N, Mecharles-Darrigol S, Nicolas G, Noury JB, Perie M, Rajabally YA, Remiche G, Rouaud V, Tard C, Salort-Campana E, Verschueren A, Viala K, Wang A, Attarian S, Boucraut J. Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera. J Neurol. 2020 Jul 16. PMID: 32676765. PubMed  
  17. Martín-Aguilar L, Lleixà C, Pascual-Goñi E. Autoimmune nodopathies, an emerging diagnostic category. Curr Opin Neurol. 2022 Oct 1;35(5):579-585. doi: 10.1097/WCO.0000000000001107. Epub 2022 Aug 19. PMID: 35989582. PubMed  
  18. Querol L. Autoimmune nodopathies: treatable neuropathies beyond traditional classifications. J Neurol Neurosurg Psychiatry. 2021 Oct;92(10):1025. doi: 10.1136/jnnp-2021-326676. Epub 2021 Aug 16. PMID: 34400541. PubMed  
  19. Pegat A, Delmont E, Svahn J, Bernard E, Lessard L, Marignier R, Bouhour F. Combined Central and Peripheral Demyelination With IgM Anti-Neurofascin 155 Antibodies: Case Report. Neurol Neuroimmunol Neuroinflamm. 2022 Mar 21;9(3):e1160. PMID: 35314490 PubMed  
  20. Valentin M, Coultas R, Sottile E. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Diabetes Mellitus: A Diagnostic Dilemma. Cureus. 2022 May 25;14(5):e25332. doi: 10.7759/cureus.25332. PMID: 35774650 PubMed  
  21. Rajabally YA, Attarian S. Chronic inflammatory demyelinating polyneuropathy and malignancy: A systematic review. Muscle Nerve. 2018 Jun;57(6):875-883. PMID: 29194677 PubMed  
  22. Deschamps N, Mathis S, Duchesne M, Ghorab K, Gallouedec G, Richard L, Boulesteix JM, Corcia P, Magy L, Vallat JM. CIDP and hemopathies, an underestimated association. J Neurol Sci. 2021 Oct 15;429:118055. doi: 10.1016/j.jns.2021.118055. Epub 2021 Aug 25. PMID: 34455207. PubMed  
  23. Seeliger T, Gingele S, Bönig L, Konen FF, Körner S, Prenzler N, Thiele T, Ernst D, Witte T, Stangel M, Skripuletz T. CIDP associated with Sjögren's syndrome. J Neurol. 2021 Aug;268(8):2908-2912. doi: 10.1007/s00415-021-10459-z. Epub 2021 Feb 21. PMID: 33611611. PubMed  
  24. Lucke IM1, Peric S2, van Lieverloo GGA1, Wieske L1, Verhamme C1, van Schaik IN1, Basta I2, Eftimov F1.. Elevated leukocyte count in cerebrospinal fluid of patients with chronic inflammatory demyelinating polyneuropathy. J Peripher Nerv Syst. 2018. pmid: 29341326 PubMed  
  25. Rajabally YA, Knopp MJ, Martin-Lamb D, Morlese J. Diagnostic value of MR imaging in the Lewis-Sumner syndrome: a case series. J Neurol Sci 2014; 342: 182-5. pmid:24825730 PubMed  
  26. Karam C, Moshe-Lilie O, Chahin N, Ragole T, Medvedova E, Silbermann R. Diagnosis of paraproteinemic neuropathy: Room for improvement. J Neurol Sci. 2020 Aug 15;415:116902. doi: 10.1016/j.jns.2020.116902. Epub 2020 May 18. PMID: 32497875. PubMed  
  27. Fehmi J, Vale T, Keddie S, Rinaldi S. Nodal and paranodal antibody-associated neuropathies. Pract Neurol. 2021 May 26:practneurol-2021-002960. doi: 10.1136/practneurol-2021-002960. Epub ahead of print. PMID: 34039750. PubMed  
  28. Martín-Aguilar L, Lleixà C, Pascual-Goñi E, Caballero-Ávila M, Martínez-Martínez L, Díaz-Manera J, Rojas-García R, Cortés-Vicente E, Turon-Sans J, de Luna N, Suárez-Calvet X, Gallardo E, Rajabally Y, Scotton S, Jacobs BC, Baars A, Cortese A, Vegezzi E, Höftberger R, Zimprich F, Roesler C, Nobile-Orazio E, Liberatore G, Hiew FL, Martínez-Piñeiro A, Carvajal A, Piñar-Morales R, Usón-Martín M, Albertí O, López-Pérez MÁ, Márquez F, Pardo-Fernández J, Muñoz-Delgado L, Cabrera-Serrano M, Ortiz N, Bartolomé M, Duman Ö, Bril V, Segura-Chávez D, Pitarokoili K, Steen C, Illa I, Querol L. Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy. Neurol Neuroimmunol Neuroinflamm. 2021 Nov 2;9(1):e1098. doi: 10.1212/NXI.0000000000001098. Erratum in: Neurol Neuroimmunol Neuroinflamm. 2021 Dec 20;9(1): PMID: 34728497 PubMed  
  29. Remiche G, Monteiro MLS, Catalano C, Hougardy JM, Delmont E, Boucraut J, Mavroudakis N. Rituximab Responsive Relapsing-Remitting IgG4 Anticontactin 1 Chronic Inflammatory Demyelinating Polyradiculoneuropathy Associated With Membranous Nephropathy: A Case Description and Brief Review. J Clin Neuromuscul Dis. 2022 Jun 1;23(4):219-226. doi: 10.1097/CND.0000000000000395. PMID: 35608646. PubMed  
  30. Fels M, Fisse AL, Schwake C, Motte J, Athanasopoulos D, Grüter T, Spenner M, Breuer T, Starz K, Heinrich D, Grond M, Keyvani K, Appeltshauser L, Doppler K, Sommer C, Ayzenberg I, Schneider-Gold C, Gold R, Pitarokoili K, Labedi A. Report of a fulminant anti-pan-neurofascin-associated neuropathy responsive to rituximab and bortezomib. J Peripher Nerv Syst. 2021 Dec;26(4):475-480. doi: 10.1111/jns.12465. Epub 2021 Sep 7. PMID: 34486194. PubMed  
  31. Hauw F, Fargeot G, Adams D, Attarian S, Cauquil C, Chanson JB, Créange A, Gendre T, Deiva K, Delmont E, Francou B, Genestet S, Kuntzer T, Latour P, Le Masson G, Magy L, Nardin C, Ochsner F, Sole G, Stojkovic T, Maisonobe T, Tard C, Van den Berghe P, Echaniz-Laguna A. Charcot-Marie-Tooth disease misdiagnosed as chronic inflammatory demyelinating polyradiculoneuropathy: An international multicentric retrospective study. Eur J Neurol. 2021 Sep;28(9):2846-2854. PMID: 34060689. PubMed  
  32. Stino AM, Naddaf E, Dyck PJ, Dyck PJB. Chronic inflammatory demyelinating polyradiculoneuropathy-Diagnostic pitfalls and treatment approach. Muscle Nerve. 2020 Sep 11. PMID: 32914902. PubMed  
  33. Rossor AM, Evans MR, Reilly MM. A practical approach to the genetic neuropathies. Pract Neurol 2015; 15: 187-198. pmid:25898997 PubMed  
  34. Rajabally YA1, Adams D2, Latour P3, Attarian S4.. Hereditary and inflammatory neuropathies: a review of reported associations, mimics and misdiagnoses. J Neurol Neurosurg Psychiatry. 2016 2016. pmid:27010614 PubMed  
  35. Campagnolo M, Taioli F, Cacciavillani M, Ruiz M, Luigetti M, Salvalaggio A, Castellani F, Testi S, Ferrarini M, Cavallaro T, Gasparotti R, Fabrizi GM, Briani C. Sporadic hereditary neuropathies misdiagnosed as chronic inflammatory demyelinating polyradiculoneuropathy: Pitfalls and red flags. J Peripher Nerv Syst. 2020 Mar;25(1):19-26. PMID: 31919945. PubMed  
  36. Singhal NS, Irodenko VS, Margeta M, Layzer RB. Sarcoid polyneuropathy masquerading as chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 2015. pmid:25786655 PubMed  
  37. Lotan I1, Hellman MA1, Steiner I1.. Diagnostic criteria of chronic inflammatory demyelinating polyneuropathy in diabetes mellitus. Acta Neurol Scand. 2015; Oct;132(4):: 278-83. pmid:25819084 PubMed  
  38. Ahdab R, Créange A, Saint-Val C, Farhat WH, Lefaucheur JP.. Rapidly progressive amyotrophic lateral sclerosis initially masquerading as a demyelinating neuropathy. Neurophysiol Clin 2013 Jun;43(3):181-7. PMID:23856174 PubMed  
  39. Hughes RA, Mehndiratta MM, Rajabally YA. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2017 Nov 29;11:CD002062. PMID: 29185258 PubMed  
  40. Vallat JM, Sommer C, Magy L.. Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition.. Lancet Neurol. 2010; 4: 402-12. PMID:20298964 PubMed  
  41. Eftimov F, Winer JB, Vermeulen M, et al. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2009;(1):CD001797. Cochrane (DOI)  
  42. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2012. pmid:22895925 PubMed  
  43. Nobile-Orazio E, Cocito D, Jann S, et al. Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial. Lancet Neurol. 2012;11:493-502. PMID:22578914 PubMed  
  44. Kuitwaard K, Hahn AF, Vermeulen M, Venance SL, van Doorn PA. Intravenous immunoglobulin response in treatment-naïve chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry. 2015 Dec;86(12):1331-6 . pmid:25515502 PubMed  
  45. Lucke IM, Wieske L, van der Kooi AJ, van Schaik IN, Eftimov F, Verhamme C.. gnosis and treatment response in the asymmetric variant of chronic inflammatory demyelinating polyneuropathy.. J Peripher Nerv Syst. 2019; Jun;24(2):: 174-179. pmid:31090121 PubMed  
  46. Allen JA, Gelinas DF, Freimer M, Runken MC, Wolfe GI. Immunoglobulin administration for the treatment of CIDP: IVIG or SCIG? J Neurol Sci. 2020 Jan 15;408:116497. PMID: 31765922. PubMed  
  47. Fehmi J, Bellanti R, Misbah SA, Bhattacharjee A, Rinaldi S. Treatment of CIDP. Pract Neurol. 2022 Sep 15:pn-2021-002991. doi: 10.1136/pn-2021-002991. Epub ahead of print. PMID: 36109154. PubMed  
  48. Kuwabara S1, Mori M1, Misawa S1, Suzuki M2, Nishiyama K3, Mutoh T4, Doi S5, Kokubun N6, Kamijo M7, Yoshikawa H8, Abe K9, Nishida Y10, Okada K11, Sekiguchi K12, Sakamoto K13, Kusunoki S14, Sobue G15, Kaji R16; Glovenin-I CIDP Study Group.. travenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: a multicentre, open-label, 52-week phase III trial. J Neurol Neurosurg Psychiatry. 2017. pmid:28768822 PubMed  
  49. Cornblath DR, van Doorn PA, Hartung HP, Merkies ISJ, Katzberg HD, Hinterberger D, Clodi E; ProCID Investigators. Randomized trial of three IVIg doses for treating chronic inflammatory demyelinating polyneuropathy. Brain. 2022 Apr 29;145(3):887-896. PMID: 35038723 PubMed  
  50. Kapoor M, Compton L, Rossor A, Hutton E, Manji H, Lunn M, Reilly M, Carr A. An approach to assessing immunoglobulin dependence in chronic inflammatory demyelinating inflammatory polyneuropathy. J Peripher Nerv Syst. 2021 Dec;26(4):461-468. PMID: 34637194. PubMed  
  51. Adrichem ME, Lucke IM, Vrancken AFJE, Goedee HS, Wieske L, Dijkgraaf MGW, Voermans NC, Notermans NC, Faber CG, Visser LH, Kuitwaard K, van Doorn PA, Merkies ISJ, de Haan RJ, van Schaik IN, Eftimov F. Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy. Brain. 2022 Jun 3;145(5):1641-1652. doi: 10.1093/brain/awac054. PMID: 35139161 PubMed  
  52. van Schaik IN, Bril V, van Geloven N, Hartung HP, Lewis RA, Sobue G, Lawo JP, Praus M, Mielke O, Durn BL, Cornblath DR, Merkies ISJ; PATH study group. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial.. Lancet Neurol. 2018. pmid:29122523 PubMed  
  53. Rajabally YA. Subcutaneous immunoglobulin therapy for inflammatory neuropathy: current evidence base and future prospects.. J Neurol Neurosurg Psychiatry 2014;85:631-637. PMID:24124042 PubMed  
  54. Markvardsen LH, Sindrup SH, Christiansen I, Olsen NK, Jakobsen J, Andersen H; Danish CIDP and MMN Study Group.. Subcutaneous immunoglobulin as first-line therapy in treatment-naive patients with chronic inflammatory demyelinating polyneuropathy: randomized controlled trial study.. Eur J Neurol. 2017. pmid:28000311 PubMed  
  55. Cocito D, Romagnolo A, Peci E, Rosso M, Lopiano L, Milla P, Merola A.. Subcutaneous vs. intravenous immunoglobulin in CIDP: pharmacokinetic and clinical response.. J Peripher Nerv Syst 2016. pmid:27251938 PubMed  
  56. Markvardsen LH, Harbo T.. Subcutaneous immunoglobulin treatment in CIDP and MMN. Efficacy, treatment satisfaction and costs.. J Neurol Sci 2017. pmid:28566163 PubMed  
  57. Alsolaihim A, Baker SK. Dose Adjustment of Subcutaneous IgG in Chronic Inflammatory Demyelinating Polyneuropathy. Case Rep Neurol. 2020 Feb 14;12(1):73-77. PMID: 32231547 PubMed  
  58. Cocito D, Peci E, Romagnolo A, Rigaldo S, Rosso M, Lopiano L, Merola A.. Subcutaneous "bolus" immunoglobulin dose in CIDP: A proof-of concept study.. J Neurol Sci 2017. pmid:28870589 PubMed  
  59. Oaklander AL1, Lunn MP2, Hughes RA3, van Schaik IN4, Frost C5, Chalk CH6.. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.. Cochrane Database Syst Rev. 2017. pmid:28084646 PubMed  
  60. van Lieverloo GGA, Peric S, Doneddu PE, Gallia F, Nikolic A, Wieske L, Verhamme C, van Schaik IN, Nobile-Orazio E, Basta I, Eftimov F. Corticosteroids in chronic inflammatory demyelinating polyneuropathy : A retrospective, multicentre study, comparing efficacy and safety of daily prednisolone, pulsed dexamethasone, and pulsed intravenous methylprednisolone. J Neurol. 2018 Sep;265(9):2052-2059. PMID: 29968199 PubMed  
  61. van Schaik IN, Eftimov F, van Doorn PA, Brusse E, van den Berg LH, van der Pol WL, Faber CG, van Oostrom JC, Vogels OJ, Hadden RD, Kleine BU, van Norden AG, Verschuuren JJ, Dijkgraaf MG, Vermeulen M.. Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial. Lancet Neurol. 2010; 3: 245-53. PMID: 20133204 PubMed  
  62. Fatehi F, Okhovat AA, Panahi A, Ziaaddini B, Rajabally YA, Nafissi S. Retrospective analysis of response to rituximab in chronic inflammatory demyelinating polyneuropathy refractory to first-line therapy. J Peripher Nerv Syst. 2021 Dec;26(4):469-474. doi: 10.1111/jns.12461. Epub 2021 Sep 10. PMID: 34469032. PubMed  
  63. Kaplan A, Brannagan TH . Evaluation of Patients with Refractory Chronic Inflammatory Demyelinating Polyneuropathy. Muscle Nerve. 2016 Jul 27. . pmid:27463215 PubMed  
  64. Pitarokoili K, Yoon MS, Kröger I, Reinacher-Schick A, Gold R, Schneider-Gold C.. Severe refractory CIDP: a case series of 10 patients treated with bortezomib.. J Neurol 2017. pmid: 28836002 PubMed  
  65. Mevorach D, Reiner I, Grau A, Ilan U, Berkun Y, Ta-Shma A, Elpeleg O, Shorer Z, Edvardson S, Tabib A.. Therapy with eculizumab for patients with CD59 p.Cys89Tyr mutation.. Ann Neurol 2016. pmid:27568864 PubMed  
  66. Burman J1, Tolf A1, Hägglund H2, Askmark H1.. Autologous haematopoietic stem cell transplantation for neurological diseases.. J Neurol Neurosurg Psychiatry. 2018. pmid: 28866625 PubMed  
  67. Press R, Askmark H, Svenningsson A, Andersen O, Axelson HW, Strömberg U, Wahlin A, Isaksson C, Johansson JE, Hägglund H.. Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP. J Neurol Neurosurg Psychiatry 2014; 85: 618-24. pmid:24262917 PubMed  
  68. Burt RK, Balabanov R, Tavee J, Han X, Sufit R, Ajroud-Driss S, Jovanovic B, Quigley K, Arnautovic I, Helenowski I, Sharrack B. Hematopoietic stem cell transplantation for chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol. 2020 Nov;267(11):3378-3391. doi: 10.1007/s00415-020-10010-6. Epub 2020 Jun 27. PMID: 32594300. PubMed  
  69. Lunn MP, Ellis L, Hadden RD, Rajabally YA, Winer JB, Reilly MM. A proposed dosing algorithm for the individualized dosing of human immunoglobulin in chronic inflammatory neuropathies. J Peripher Nerv Syst. 2016 Mar;21(1):33-7 . pmid: 26757367 PubMed  
  70. Doneddu PE, Mandia D, Gentile F, Gallia F, Liberatore G, Terenghi F, Ruiz M, Nobile-Orazio E. Home monitoring of maintenance intravenous immunoglobulin therapy in patients with chronic inflammatory neuropathy. J Peripher Nerv Syst. 2020 Sep;25(3):238-246. PMID: 32470190. PubMed  
  71. Sadjadi R, Peric S, Gwathmey K, Bozovic I, Aleksa P, Bjelica B, Burns T, Basta I. Psychometric longitudinal evaluation of the Chronic Acquired Polyneuropathy Patient-Reported Index (CAPPRI) in patients with Chronic Inflammatory Demyelinating Polyneuropathy. Muscle Nerve. 2020 Oct 11. PMID: 33043466. PubMed  
  72. Rajabally YA, Afzal S, Ghasemi M. Minimal important differences and self-identifying treatment response in chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 2021 Jul;64(1):37-42. doi: 10.1002/mus.27250. Epub 2021 Apr 20. PMID: 33835480. PubMed  
  73. Van den Bergh PY, Hadden RD, Bouche P, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision. Eur J Neurol. 2010; 17: 356-363. pmid:20456730 PubMed  
  74. Kohle F, Kuwabara S, Lehmann HC. Chronic inflammatory demyelinating polyneuropathy and pregnancy: systematic review. J Neurol Neurosurg Psychiatry. 2021 May;92(5):473-478. doi: 10.1136/jnnp-2020-325321. Epub 2021 Feb 9. PMID: 33563801. PubMed  
  75. Allen JA, Lewis RA. Treatment of chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 2022 Nov;66(5):552-557. doi: 10.1002/mus.27709. Epub 2022 Sep 6. PMID: 35994242. PubMed  
  • Unn Ljøstad, spesialist i nevrologi, professor PhD
  • Åse Mygland, spesialist i nevrologi, professor dr med
  • Christian Vedeler, spesialist i nevrologi, professor dr med